Healthcare / Health Information ServicesKOSDAQ
$4485.00
+120.00 (+2.75%)
FCF base 3Y
n/d
n/d CAGR · yield n/d
FCF base 5Y
n/d
n/d base · n/d expected
Precio de entrada
n/d
MOS 24% · confianza 25%
FCF escenarios
weak_data · normalized FCF $6.9B · quality 79.7/100
Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.
SA Score
50/100
C
Piotroski
3/9
balance/quality
Valuation
50/100
+0.0% upside
5Y CAGR
+0.0%
50/100
Data QA
16/100
SEC 0%
Sin guardar todavía.
Market Cap
$67.7B
P/E
9.5x
↓EV/EBITDA
6.0x
↓ROE
10.0%
↑Gross Margin
37.2%
↓Debt/Equity
0.00
↓TradingView lightweight chart
Absolute Values (Left Axis)
Ratios / Percentages (Right Axis)
Financial statement dashboard
2022–2025 · 3 años de histórico normalizado
Revenue CAGR
+0.8%
FCF CAGR
+8.6%
FCF margin
19.1%
FCF / Net income
0.93x
Latest source
Provider fallback
Margin decomposition
Último año: revenue $35.98B · net income $7.37B · FCF $6.87B
Gross margin
Operating margin
Net margin
FCF margin
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $35.98B | $35.98B | $37.07B | $33.46B | $35.13B |
| Net Income | $7.37B | $7.37B | $7.76B | $5.54B | $4.87B |
| EBITDA | $10.43B | $10.43B | $10.83B | $8.55B | $8.69B |
| EPS | 471.00 | 471.00 | 479.00 | 338.00 | 296.00 |
| Gross Margin | 37.2% | 37.2% | 37.2% | 39.6% | 34.2% |
| Operating Margin | 16.3% | 16.3% | 18.0% | 18.6% | 17.5% |
| Net Margin | 20.5% | 20.5% | 20.9% | 16.6% | 13.9% |
| Balance Sheet | |||||
| Debt/Equity | 0.00 | 0.00 | 0.01 | 0.03 | 0.06 |
| Current Ratio | 3.94 | 3.94 | — | — | — |
| Cash Flow | |||||
| Free Cash Flow | $6.87B | $6.87B | $4.07B | $7.45B | $5.37B |
| Returns | |||||
| ROE | 10.0% | 10.0% | 11.0% | 8.4% | 7.8% |
| Valuation | |||||
| P/E | 9.52 | 9.52 | 10.42 | 17.75 | 21.25 |
| EV/EBITDA | 5.97 | 5.97 | 6.96 | 10.87 | 11.53 |
| P/B | 0.95 | 0.95 | 1.15 | 1.49 | 1.65 |
| Growth & Yield | |||||
| Revenue Growth | -2.9% | -2.9% | 10.8% | -4.8% | — |
| EPS Growth | -1.7% | -1.7% | 41.7% | 14.2% | — |
| Dividend Yield | 1.5% | 1.5% | — | — | — |
Revenue, Net Income & Free Cash Flow ($B)
Margins (%)
Returns (%)
Leverage & Liquidity
3Y implied EPS CAGR
-5.5%
EPS terminal req.
$397.97
Spread vs growth
3.8%
5Y implied EPS CAGR
0.4%
EPS terminal req.
$481.54
Spread vs growth
-2.1%
10Y implied EPS CAGR
5.1%
EPS terminal req.
$775.53
Spread vs growth
-6.8%
Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.
Total return
-11.6%
Start / end P/E
10.8x → 9.5x
EPS bridge
479.00 → 471.00
Residual
+0.2%
Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.